Earning Analysis
Welcome to our in-depth analysis of (PTN) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Surprise Analysis
| FY2025Q2 | 2025-02-13 | Pre-Market | -0.42 | -0.12 | +71.43 | - | 0.00 | - | +7.10 | +3.06 |
| FY2025Q1 | 2024-11-14 | - | -0.51 | -0.39 | +23.53 | - | - | - | -10.08 | -23.53 |
| - | 2024-10-01 | Pre-Market | - | - | - | - | - | - | -1.12 | +2.25 |
| FY2024Q3 | 2024-05-15 | - | -0.66 | -0.53 | +19.70 | 80.67K | - | - | -14.11 | -14.11 |
| FY2024Q2 | 2024-02-14 | - | -0.43 | -0.56 | -30.23 | 6.29M | 2.03M | -67.67 | +4.81 | -24.56 |
| FY2024Q1 | 2023-11-14 | - | -0.75 | -0.48 | +36.00 | 5.68M | 2.11M | -62.91 | -4.48 | -2.99 |
| FY2023Q4 | 2023-09-28 | - | -0.59 | -0.91 | -54.24 | 1.36M | 1.76M | +29.78 | -9.09 | +4.85 |
| - | 2023-05-16 | - | -0.59 | -0.63 | -6.78 | - | - | - | -0.39 | -4.63 |
| - | 2023-02-14 | - | -0.77 | -0.66 | +14.29 | - | - | - | -4.23 | -9.67 |
| - | 2022-11-14 | - | -1.34 | -0.86 | +35.82 | - | - | - | -7.71 | -5.78 |
PTN Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, reported performance for FY2025Q2, announced on 2025-02-13. The company achieved an EPS of -0.12, compared to analyst estimates of -0.42 by 71.43% . Revenue for the quarter reached 0.00 compared to expectations of 0.00 by % .
The stock price reacted with a 7.10% one-day change and a 3.06% five-day change following the earnings release. These movements reflect market reaction in growth trajectory and strategic initiatives.
PTN Earnings Forecast
Looking ahead, (PTN) remains a focal point for investors seeking growth opportunities. Analyst forecasts for project quarter revenue of and an EPS of .
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been No Change by 0%, while EPS estimates have been No Change by 0%. For the upcoming , revenue estimates have been adjusted No Change by % . These revisions correlate with a % change in stock price over the same period, suggesting potential buying opportunities for investors who believe in long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between PTN's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
Revenue Estimates for Q3 2025
No Change
0.00%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:1.50M
--
EPS Estimate-Annual FY 2025:0
—
Stock Price0.09
PTN Revenue and EPS Performance: A Historical Perspective
revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q2 (2025-02-13,Pre-Market):
EPS: -0.12 (Actual) vs.-0.42 (Estimate) (71.43%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: 7.10%(1-Day), 3.06%(5-Day)
FY2025Q1 (2024-11-14,):
EPS: -0.39 (Actual) vs.-0.51 (Estimate) (23.53%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: -10.08%(1-Day), -23.53%(5-Day)
(2024-10-01,Pre-Market):
EPS: (Actual) vs. (Estimate) (%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: -1.12%(1-Day), 2.25%(5-Day)
Earnings Reaction
The chart below shows how PTN performed 10 days before and after its earnings report, based on data from the past quarters. Typically, PTN sees a +13.27% change in stock price 10 days leading up to the earnings, and a -6.47% change 10 days following the report. On the earnings day itself, the stock moves by -3.93%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in DEC/2024, the stock changed -5.66% on the day following the earnings release and then changed by -13.88% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
Palatin Technologies Inc (PTN) Q3 2025 Earnings Call Summary
Negative
2025-05-20
The earnings call highlights several negative aspects: trading suspension and delisting from NYSE, no revenue due to the sale of Vyleesi, and a significant cash position decrease. Although operating expenses and net loss decreased, concerns about financial viability and market perception persist. The Q&A section provided limited positive insights, with management's unclear responses adding to uncertainties. The absence of shareholder return plans further contributes to a negative outlook. Given these factors, a negative stock price movement is expected.
Palatin Technologies, Inc. (PTN) Q1 2025 Earnings Conference Call Summary
Negative
2024-11-14
The earnings call summary indicates significant challenges: liquidity concerns with cash dropping from $9.5M to $2.4M, no product sales in Q1 2025, and increased net loss. Despite a deferred payment and potential partnerships, the focus on MCR-4 obesity limits diversification and increases risk. Q&A insights reveal interest but lack concrete partnership details, adding uncertainty. Overall, the negative financials and strategic risks outweigh the potential positives, leading to a negative sentiment prediction.
People Also Watch
ATER
Aterian Inc
1.300
USD
0.00%
CCM
Concord Medical Services Holdings Ltd
5.500
USD
+10.00%
GELS
Gelteq Ltd
1.420
USD
-7.79%
OMEX
Odyssey Marine Exploration Inc
1.650
USD
+5.77%
GYRO
Gyrodyne LLC
10.330
USD
+2.36%
AMS
American Shared Hospital Services
2.580
USD
+0.51%
ATHA
Athira Pharma Inc
0.390
USD
+1.30%
MGIH
Millennium Group International Holdings Ltd
1.630
USD
+5.16%
YJ
Yunji Inc
1.760
USD
-4.35%
KIRK
Brand House Collective Inc
0
USD
+10.24%
FAQ
What were the key highlights of PTN’s latest earnings report for FY2025Q2?
PTN reported its FY2025Q2 earnings on 2025-02-13, showcasing a revenue of 0.00 against an estimate of 0.00, resulting in a 0% surprise. The EPS was -0.12, surpassing the expected -0.42 by 71.43% . The stock experienced a 7.1% price change on the earnings day and a 3.06% change over the next five days, reflecting market reactions to the results.
How did PTN’s stock price react after the FY2025Q2 earnings release?
What are the revenue and EPS estimates for PTN for undefined?
How does PTN’s stock price correlate with earnings forecast revisions?
What should investors expect from PTN’s next earnings report?